Technical Analysis for SYN - Synthetic Biologics, Inc.

Grade Last Price % Change Price Change
grade F 0.69 2.99% 0.02
SYN closed up 2.99 percent on Friday, January 18, 2019, on 1.32 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical SYN trend table...

Date Alert Name Type % Chg
Jan 18 50 DMA Resistance Bearish 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Doji - Bearish? Reversal 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Upper Bollinger Band Touch Strength 0.00%
Jan 17 Crossed Above 20 DMA Bullish 2.99%
Jan 17 Pocket Pivot Bullish Swing Setup 2.99%
Jan 17 Wide Bands Range Expansion 2.99%
Jan 16 Fell Below 20 DMA Bearish 15.38%
Jan 16 Wide Bands Range Expansion 15.38%

Older signals for SYN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Synthetics Biologics, Inc., a biotechnology company, focuses on the development of biologics for the prevention and treatment of serious infectious diseases. The company's product candidates include Trimesta, which is in Phase II clinical trial for the treatment of relapsing-remitting multiple sclerosis and cognitive dysfunction in multiple sclerosis; SYN-004, which is in Phase II clinical trial for the treatment of clostridium difficile infection prevention; SYN-005, which is in preclinical stage for the treatment of pertussis; and SYN-001, which is in discovery stage for the treatment of acinetobacter infection. It has an agreement with Meda AB for the development and commercialization of Effirma (flupirtine) for fibromyalgia in the United States, Canada, and Japan, as well as with The University of Texas at Austin, Intrexon Corporation, and the Regents of the University of California. The company was formerly known as Adeona Pharmaceuticals, Inc. and changed its name to Synthetics Biologics, Inc. in February 2012. Synthetics Biologics, Inc. was founded in 2001 and is based in Rockville, Maryland.
Is SYN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 710.5
52 Week Low 0.51
Average Volume 346,022
200-Day Moving Average 130.9763
50-Day Moving Average 0.6976
20-Day Moving Average 0.6143
10-Day Moving Average 0.6549
Average True Range 0.067
ADX 9.74
+DI 22.3551
-DI 18.704
Chandelier Exit (Long, 3 ATRs ) 0.519
Chandelier Exit (Short, 3 ATRs ) 0.711
Upper Bollinger Band 0.7188
Lower Bollinger Band 0.5098
Percent B (%b) 0.86
BandWidth 34.022465
MACD Line -0.0551
MACD Signal Line -0.0901
MACD Histogram 0.035
Fundamentals Value
Market Cap 88.49 Million
Num Shares 128 Million
EPS -0.16
Price-to-Earnings (P/E) Ratio -4.21
Price-to-Sales 0.00
Price-to-Book 21.83
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.77
Resistance 3 (R3) 0.77 0.74 0.75
Resistance 2 (R2) 0.74 0.72 0.74 0.75
Resistance 1 (R1) 0.72 0.71 0.72 0.72 0.74
Pivot Point 0.69 0.69 0.69 0.69 0.69
Support 1 (S1) 0.67 0.67 0.67 0.67 0.64
Support 2 (S2) 0.64 0.66 0.64 0.63
Support 3 (S3) 0.62 0.64 0.63
Support 4 (S4) 0.62